Rapidly Evolving Stem Cells Market Opens Up Doors for Related Research Tools, Says Frost & Sullivan

Rapidly Evolving Stem Cells Market Opens Up Doors for Related Research Tools, Says Frost & Sullivan PR Newswire LONDON, May 30, 2012 - Lack of Venture Capital Infusions Threatens to Slow Pace of Research and Market Development LONDON, May 30, 2012 /PRNewswire/ -- Stem cell research is very dynamic with research trends, focus, and approaches evolving extremely rapidly. The tool market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments. New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), Strategic Analysis of the European Stem Cell Research Tools Market, finds that the market earned revenues of $148.4 million in 2011 and estimates this to reach $322.0 million in 2017. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools, and protein biochemistry tools. "Firms with the capacity to supply tools for stem cell research will increase as the science matures," notes Frost & Sullivan Senior Research Analyst Divyaa Ravishankar. "Soon demand and supply will achieve a degree of equilibrium." Already, a sizeable stem cell research products market has emerged. Another positive sign for the market has been enhanced industry- academic collaboration. A key step forward has been the stem cell regulations in a few countries allowing the use of certain cell lines.